对三种Y形联体与PI3Kα的相互作用的结构见解
Qingtong Zhou1, Xiao Liu1, Dario Neri2
1Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
新的Y形联体以独特的方式与酸酸3-酶α (PI3Kα) 结合,为癌症药物开发提供了一种新的策略. 这些化合物避免了与当前PI3Kα抑制剂相关的典型安全问题.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 药用化学 医学化学
背景情况:
- 第IA类酸酸盐3-酶α (PI3Kα) 在癌症中经常发生突变,使其成为关键的药物标.
- 由于选择性差,现有的PI3Kα抑制剂面临安全问题.
- 对于有效的PI3Kα向疗法,需要新的化学支架和抑制机制.
研究的目的:
- 阐明PI3Kα与新型Y形联结体相互作用的结构基础.
- 探索一种独特的激酶抑制机制,与ATP竞争性结合不同.
- 为下一代PI3Kα抑制剂的合理设计提供见解.
主要方法:
- 使用冷电子显微镜 (cryo-EM) 来确定PI3Kα与Y形联结体复合的结构.
- 结构分析侧重于连接体结合模式及其对PI3Kα构成的影响.
- 进行了结构-活性关系研究,以了解差异性的结合亲缘关系.
主要成果:
- 三个Y形联结体 (cpd16,cpd17,cpd18) 与PI3Kα复合在一起.
- 基cpd17表现出独特的结合模式,臂部占据不同的口袋,并诱导非基的PI3Kα形状.
- 结构分析揭示了立体化学修饰如何影响连接体结合亲和力.
结论:
- 这种Y形联结体通过非ATP竞争机制结合PI3Kα,从而诱导出独特的构造状态.
- 独特的结合模式提供了一个潜在的策略,以克服当前抑制剂的选择性和安全性问题.
- 这些发现为开发针对癌症PI3Kα的新型治疗剂提供了基础.
更多相关视频
10:52Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation
Published on: January 6, 2016
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The JAK-STAT Signaling Pathway
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
IP3/DAG Signaling Pathway
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
